杨旺伟,刘毅,李妍,袁铭,李成祥,郭文怡,李伟杰,牟方俊,陈仁娟,陶凌

• 1:空军军医大学西京医院心脏内科

摘要(Abstract)：

目的分析支架内再狭窄患者光学相干断层成像(OCT)影像学表现特征。方法回顾性分析2016年1月至2018年12月在西京医院行冠状动脉造影诊断为支架内再狭窄并行OCT检查患者38例,共42处支架内再狭窄病变。支架内再狭窄时间为52.0(17.5, 84.0)个月。根据发生时间分为支架内再狭窄时间≤20个月组(11例,12处病变,中位随访时间8.5个月)和支架内再狭窄时间>20个月组(27例,30处病变,中位随访时间75个月)。结果 38例患者平均年龄为(62.84±11.08)岁,其中男性22例(57.9%),高血压病19例(50.0%),糖尿病17例(44.7%)。定量冠状动脉造影(QCA)分析结果显示,最小管腔直径为(0.88±0.55)mm,直径再狭窄率为(66.41±18.51)%。OCT对支架内再狭窄可能原因分析,支架膨胀不全、贴壁不良、支架直径偏小分别占21.1%、10.5%以及5.3%。OCT对血栓性质分析,血栓见于21.1%患者,其中红色血栓、白色血栓及混合血栓分别占2.6%、5.3%以及13.2%。支架内再狭窄时间>20个月组钙化(26.7%比8.3%,P=0.372)、薄纤维帽粥样硬化斑块(10.0%比0,P=0.556)、巨噬细胞(40.0%比8.3%,P=0.102)、斑块侵蚀(50.0%比16.7%, P=0.101)与支架内再狭窄时间≤20个月组发生率相比,差异均无统计学意义,但均有升高趋势,而脂质(60.0%比25.0%,P=0.040)差异有统计学意义。结论支架内再狭窄患者伴有支架膨胀不全或贴壁不良等手术操作因素,随着时间的延长支架内再狭窄患者新生斑块不稳定性有增加趋势。

关键词(KeyWords)： 经皮冠状动脉介入治疗;支架内再狭窄;光学相干断层成像

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杨旺伟,刘毅,李妍,袁铭,李成祥,郭文怡,李伟杰,牟方俊,陈仁娟,陶凌

参考文献(References)：

• [1] Lee MS, Banka G. In-stent restenosis. Interv Cardiol Clin,2016,5(2):211-220.
• [2]张铮，高磊，曹丰.光学相干断层成像在药物洗脱支架术后再狭窄治疗中的作用.中国介入心脏病学杂志，2018, 26(7):400-402.
• [3]刘臣，周鹏，谭宇，等.冠状动脉造影识别急性心肌梗死罪犯斑块类型价值的研究.中国介入心脏病学杂志，2019, 27(5):243-248.
• [4] Kokkinidis DG, Waldo SW, Armstrong EJ. Treatment of coronary artery in-stent restenosis. Expert Rev Cardiovasc Ther,2017,15(3):191-202.
• [5] Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation,2011,123(25):2954-2963.
• [6] Habara M, Terashima M, Nasu K, et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation:an optical coherence tomography study. Eur Heart J Cardiovasc Imaging,2013,14(3):276-284.
• [7] Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies:a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol,2012,59(12):1058-1072.
• [8] Xhepa E, Byrne RA, Rivero F, et al. Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis. Clin Res Cardiol,2019.[Epub ahead of print]
• [9] Elmore JB, Mehanna E, Parikh SA, et al. Restenosis of the coronary arteries:past, present, future directions. Interv Cardiol Clin,2016,5(3):281-293.
• [10] Claessen BE, Henriques JP, Jaff er FA, et al. Stent thrombosis:a clinical perspective. JACC Cardiovasc Interv,2014,7(10):1081-1092.
• [11] van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis:the Dutch Stent Thrombosis Registry.J Am Coll Cardiol,2009,53(16):1399-1409.